These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9655967)

  • 1. [Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].
    Takai A
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1091-101. PubMed ID: 9655967
    [No Abstract]   [Full Text] [Related]  

  • 2. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
    McCluskey A; Sim AT; Sakoff JA
    J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor promotion by inhibitors of protein phosphatase 1 and 2A].
    Suganuma M; Fujiki H
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1102-10. PubMed ID: 9655968
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells.
    Ford SL; Abayasekara DR; Persaud SJ; Jones PM
    J Endocrinol; 1996 Aug; 150(2):205-11. PubMed ID: 8869587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
    Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
    Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
    Gupta V; Ogawa AK; Du X; Houk KN; Armstrong RW
    J Med Chem; 1997 Sep; 40(20):3199-206. PubMed ID: 9379439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.
    Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S
    J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse.
    Swingle M; Ni L; Honkanen RE
    Methods Mol Biol; 2007; 365():23-38. PubMed ID: 17200551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung.
    Bastan R; Peirce MJ; Peachell PT
    Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
    Fujiki H; Suganuma M
    Adv Cancer Res; 1993; 61():143-94. PubMed ID: 8394044
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors.
    Fladmark KE; Brustugun OT; Hovland R; Boe R; Gjertsen BT; Zhivotovsky B; Døskeland SO
    Cell Death Differ; 1999 Nov; 6(11):1099-108. PubMed ID: 10578179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A.
    MacKintosh C; Klumpp S
    FEBS Lett; 1990 Dec; 277(1-2):137-40. PubMed ID: 2176611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-serine/threonine phosphatases in rat islets of Langerhans: identification and effect on insulin secretion.
    Murphy LI; Jones PM
    Mol Cell Endocrinol; 1996 Mar; 117(2):195-202. PubMed ID: 8737380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors.
    Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K
    J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Total synthesis and conformational analysis of inhibitors].
    Tsuboi K; Isobe M
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1083-90. PubMed ID: 9655966
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
    Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
    FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts.
    Ariza RR; Keyse SM; Moggs JG; Wood RD
    Nucleic Acids Res; 1996 Feb; 24(3):433-40. PubMed ID: 8602355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of protein phosphatases (okadaic acid and tautomycin) block sea urchin development.
    Troll W; Sueoka N; Sueoka E; Laskin JD; Heck DE
    Biol Bull; 1995; 189(2):201. PubMed ID: 8541399
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid.
    Tanaka H; Katagiri M; Arima S; Matsuzaki K; Inokoshi J; Omura S
    Biochem Biophys Res Commun; 1995 Nov; 216(1):291-7. PubMed ID: 7488103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
    Ubukata M; Koshino H; Yamasaki C; Fujita K; Isono K
    J Antibiot (Tokyo); 1997 Oct; 50(10):801-7. PubMed ID: 9402983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.